Patent · US Expired

4-pyrrolidino-phenyl-benzyl ether derivatives

US7151111B2 · kind B2 · utility

2Cited by

1References

51Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Hans Iding · Rheinfelden (Baden), DE
Synese Jolidon · Blauen, CH
Daniela Krummenacher · Rheinfelden, CH
Rosa Maria Rodriguez-Sarmiento · Basel, CH
Andrew Thomas · Birsfelden, CH
Beat Wirz · Basel, CH
Wolfgang Wostl · Weil am Rhein, DE
Rene Wyler · Zürich, CH

Key dates

Filing date	Sep 18, 2003
Grant date	Dec 19, 2006
Priority date	—
Expiry date	Sep 13, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D207/277
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to racemic or enantiomerically pure 4-pyrrolidino derivatives, processes for their preparation, pharmaceutical compositions comprising said derivatives, and their use in the prevention and treatment of a disease which is mediated by a monoamine oxidase B inhibitor, in particular Alzheimer's disease and senile dementia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.